Carrie D'Andrea

Technik-/Wissenschafts-/F&E-Leiter bei ACASTI PHARMA INC.

Vermögen: - $ am 31.05.2024

52 Jahre

Health Technology

Consumer Services

Aktive Positionen von Carrie D'Andrea

Unternehmen	Position	Beginn	Ende
ACASTI PHARMA INC.	Technik-/Wissenschafts-/F&E-Leiter	08.05.2023	-

Unternehmen	Position	Beginn	Ende
EryDel SpA EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.	Corporate Officer/Principal	01.10.2020	01.04.2021
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Technik-/Wissenschafts-/F&E-Leiter	01.10.2014	01.03.2019

Temple University (Pennsylvania)

Graduate Degree

International

Vereinigte Staaten	4
Italien	2

Operativ

Chief Tech/Sci/R&D Officer	2
Graduate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ACASTI PHARMA INC.	Health Technology

Private Unternehmen	2
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Health Technology
EryDel SpA EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.	Health Technology

Private Unternehmen

Health Technology